[go: up one dir, main page]

Eng et al., 1992 - Google Patents

Exendin-3 and-4 are insulin secretagogues

Eng et al., 1992

Document ID
163332775416950327
Author
Eng J
Eng C
Publication year
Publication venue
Regulatory Peptides

External Links

Continue reading at scholar.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Meier et al. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives
PEDERSON et al. The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas
Harris Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Creutzfeldt The [pre-] history of the incretin concept
Giugliano Morphine, opioid peptides, and pancreatic islet function
JP3579048B2 (en) Use of peptides
CN104323981B (en) Rapid establishment and/or termination of substantially steady state drug delivery
Singer Neurohormonal control of pancreatic enzyme secretion in animals
Guglielmi et al. GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products
Efendić et al. Sulphonylurea (Glibenclamide) enhances somatostatin and inhibits glucagon release induced by arginine
Konturek Somatostatin and the gastrointestinal secretions
Holst Incretin therapy for diabetes mellitus type 2
Sandler et al. Effective long‐term treatment of acromegaly with a long‐acting somatostatin analogue (SMS 201–995)
Delle Fave et al. Bombesin effects on human GI functions
Spinas et al. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus
Rehfeld Gastrointestinal hormones and insulin secretion
Yamamoto et al. A possible role of GLP-1 in the pathophysiology of early dumping syndrome
CN120647747A (en) Human amylin analog polypeptides and methods of use
Sivakumar et al. Role of GLP-1 analogs in the management of diabetes and its secondary complication
Eng et al. Exendin-3 and-4 are insulin secretagogues
Ottlecz et al. The effects of gastric inhibitory polypeptide (GIP) on the release of anterior pituitary hormones
Santini et al. Diagnostic tool of endocrine markers in the diagnosis of G-hyperplasia
Holst Glucagon-like peptide-1: physiology and therapeutic potential
D'Alessio Peptide hormone regulation of islet cells
KR20220062592A (en) Treatment of type 2 diabetes mellitus